Abstract
Background
Cervix cancer is a significant health problem. As access to quality care in Small Island Developing States improves, and cancer centers become established, providers of care can summarize local experience to benchmark system quality and look for ways to further improve value.
Methods
This is a retrospective study of all cases of cervix cancer managed 2006–2016 at The Cancer Centre Bahamas, in conjunction with Princess Margaret Hospital, Nassau, affiliated with The University of West Indies. Seventy-two women received curative radiotherapy or chemoradiotherapy. Herein are reported presenting characteristics, treatments, waiting and overall treatment times, plus outcomes of recurrence, survival, and adverse events.
Results
For 68 newly diagnosed cases, median waiting time (diagnosis to commencing treatment) was 110 days. It was 90 days for those 47 cases who had no prior surgery or neoadjuvant chemotherapy. Overall, 99% of intended external radiotherapy fractions, 74% of brachytherapy sessions, and 79% of concurrent weekly chemotherapy were administered. For all 72 cases, median overall treatment time was 63 days; and for the 47 case sub-group, it was 78 days during 2006–2010 and 65 days during 2011–2016 (p = 0.005), so improving over calendar time. Four cases experienced grade 3–4 toxicities. Twelve had urological complications from disease or treatment. Five cases experienced local failure; eight experienced distant failure. Newly diagnosed stage 2B (26/72) had a 2-year survival of 71%.
Conclusion
This report demonstrates the impact of providing curative radiation-based treatments for cervical cancer in a small state. It suggests ways to further improve operations and justifies additional research.
Similar content being viewed by others
References
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Hacker N, Friedlander M. Cervical cancer. In: Bereck L, Neville N (eds) Bereck & Hacker’s gynecologic oncology. 5th edn: Wolters Kluwer/Lippincott Williams & Wilkins; 2010. pp 341–395
Garland SM, Kjaer SK, Munoz N, Block SL, Brown DR, DiNubile MJ et al (2016) Impact and Effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis 63(4):519–527
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2007) Summary report on HPV and cervical cancer statistics in Spain. Available from: http://www.who.int/hpvcentre
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR et al (2015) Cervical cancer, version 2.2015. J Natl Compr Canc Network 13(4):395–404
Rose PG, Bundy BN (2002) Chemoradiation for locally advanced cervical cancer. Does it help? J Clin Oncol 20:891
National Comprehensive Cancer Network (2016) Cervical cancer. Version 1.2017—October 10,
World Health Organization (2014) Comprehensive cervical cancer control. A guide to essential practice. Second edition
Fisher CM (2017) Treatment disparities in locally advanced cervical cancer impact survival. An analysis of the National Cancer Database. Findings reported by interview posted on-line at cancer network. 20
Razzaghi H, Quesnel-Crooks S, Sherman R, Joseph R, Kohler B, Andall-Brereton G, Ivey MA et al (2016) Leading causes of cancer mortality—Caribbean Region, 2003–2013. MMWR 65:1395–1400
Globocan (2012) Estimated cancer incidence, Mortality and prevalence worldwide in 2012. Available on-line at globocan.iarc.fr
OECS Secretariat (2005) Feasibility study on the Establishment of and OECS radiotherapy Centre, Final Report. http://www.oecs.org/oecs-library/ (under category of Reports)
Isabel do Nascimento M, Azevedo e Silva G (2016) Waiting time for radiotherapy in women with cervical cancer. Rev Saude Publica. doi:10.1590/S0034-8910.2015049005953
Huang Z, Mayr NA, Gao M, Lo SS, Wang JZ, Jia G et al (2012) The onset time of tumor repopulation for cervical cancer—first evidence from clinical data. Int J Radiat Oncol Biol Phys 84:478–484
Brown C, Sin Quee C, Spencer H, Roberts R, Coleman H, Francis B et al (2006) Partnered care in The Bahamas: a model of advanced healthcare delivery for developing countries. West Indies Med J 55:30–36
Butler R, Halliday D, Turner E, Wallace R, Frandson M (2016) Trends in gynaecological malignancies at The Princess Margaret Hospital in The Bahamas: 2000–2014. West Indies Med J 65(S5):28
Benk V, Przybysz R, McGowan T, Paszat L (2006) Waiting times for radiation therapy in Ontario. Can J Surgery 49:16–21
Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. NEJM 340:1144–1153
Kadkhodayan S, Shandiz FH, Toussi MS, Aghaee MA, Farshidi F, Dehghan P (2013) Concurrent chemoradiotherapy without brachytherapy in locally advanced cervical cancer. Iran J Cancer Prev 5:195–200
Hsieh CH, Wei MC, Hsu YP, Chong NS, Chen YJ, Hsiao SM et al (2010) Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer 10:637
Pfaendler KS, Wenzel L, Mechanic MB, Penner KR (2015) Cervical cancer survivorship: long-term quality of life and social support. Clinical Ther 37:39–48
Knoos T (2015) QA procedures needed for advanced RT techniques and its impact on treatment outcome. J Phys 573:012001
International Atomic Energy Agency (2016) Accuracy Requirements and Uncertainties in Radiotherapy. IAEA Human Health Series 31;178
Abadir AM, Lang A, Abenhaim HA (2014) Influence of qualitative research on women’s health screening guidelines. Am J Obstet Gynecol 210:44
Barello S, Triberti S, Graffigna G, Libreri C, Serino S, Hibbard J et al (2015) eHealth for patient engagement: a systematic review. Front Psychol 6:2013
Halliday D, Butler R, Francis D, Thompson J, Joseph M, Ragin CC (2013) Knowledge and attitudes toward HPV and HPV vaccines in the Bahamas. West Indies Med J 62:731–737
Matthews M, Ryan D, Bulman D (2015) What does satisfaction with wait times mean to cancer patients? BMC Cancer 15:1017
International Atomic Energy Agency. CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer’s Response to Radiotherapy. https://clinicaltrials.gov/ct2/show/NCT00122772
Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY et al (2016) Advances and concepts in cervical cancer trials: a roadmap for the future. Int J Gynecol Cancer 26:199–207
United Nations. Sustainable development knowledge platform. Access at: https://sustainabledevelopment.un.org/topics/sids/list
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
All procedures performed were in accordance with the ethical standards of the institutions and with the 1964 Helsinki Declaration and its later amendments and comparable ethics standards.
Rights and permissions
About this article
Cite this article
Jones, G., Kellini, O., Girgis, N. et al. Experience with curative radiotherapy for cervix cancer in the Bahamas for 2006–2016. Cancer Causes Control 28, 1275–1283 (2017). https://doi.org/10.1007/s10552-017-0964-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-017-0964-1